Mass General: Tocilizumab Does Not Improve Symptoms or Prevent Death in Moderately Ill Hospitalized Patients With COVID-19
October 23, 2020
October 23, 2020
BOSTON, Massachusetts, Oct. 23 -- Massachusetts General Hospital issued the following news release:
The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ill hospitalized patients with COVID-19, according to a new study led by researchers at Massachusetts General Hospital (MGH). The study, published in the New England Journal of Medicine (NEJM), casts doubt on earlier research suggesting that tocil . . .
The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ill hospitalized patients with COVID-19, according to a new study led by researchers at Massachusetts General Hospital (MGH). The study, published in the New England Journal of Medicine (NEJM), casts doubt on earlier research suggesting that tocil . . .